Search
for
Sort by
Research 271–300 of 274
- Understanding the Association Between Mental Health and Hair Loss
- Biochemical analysis and investigation on the prospective applications of alkaline protease from a Bacillus cereus strain
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Poster Presentations at the 28th Joint Meeting of the International Society of Dermatopathology, March 5–6, 2025, Orlando, Florida, USA
- Patterns of psychotropic medication prescribing and potential drug-hormone interactions among transgender and gender-diverse adults within 2 years of hormone therapy
- An Update on Drug-Induced Pigmentation
- Severe hair loss associated with psyc hotropic drugs in psychiatric inpatients—Data from an observational pharmacovigilance program in German-speaking countries
- Bipolar Patients and Bullous Pemphigoid after Risperidone Long-Acting Injectable: A Case Report and a Review of the Literature
- Selection of Anti-Depressants in Geriatric Dermatoses- A Questionnaire Study of Dermatologists in Western Rajasthan, India
- Adverse Cutaneous Reactions to Antidepressants
- Spectrum and signals of medication-associated cognitive disorder: a comprehensive disproportionality analysis with cross-database validation
- Selection of Anti-Depressants in Geriatric Dermatoses- A Questionnaire Study of Dermatologists in Western Rajasthan, India
- A Gender Hypothesis of sex disparities in adverse drug events
- The Prevention of Skin Tears—A Focus on Vulnerable Populations from Older Adults to Critically Ill Patients: ISTAP Part 1
- Management of psychiatric disorders with HIV and dermatological disorders
- Drug-associated insomnia: A pharmacovigilance study based on FDA adverse event reporting system
- State of the Science Burn Research: Burns in the Elderly
- Trichotillomania Successfully Treated With Risperidone and Naltrexone: A Geriatric Case Report
- 5α-Reductase Isoenzymes: From Neurosteroid Biosynthesis to Neuropsychiatric Outcomes
- Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System
- Alopecia Due to Psychotropic Medications
- Psychotropic Medication and Drug-Related Alopecia
- Psychotropic Medications and the Skin
- Psychotropic Treatment of Psychodermatologic Disorders
- Dermatologic Side Effects of Psychotropic Medications
- Adverse cutaneous effects of psychotropic medications
- The role of biotransformation processes in mediating interactions between psychotropic drugs and natural products
- Adverse effects of common medications on male fertility
- [Drug-induced alopecia: review of the literature].
- Trichotillomania: a case report with clinical and dermatoscopic differential diagnosis with alopecia areata